2 recruiting, 1 completed, 1 terminated. 2 Phase 1, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
Follow Osivelotor: new trials by email Literature Review of Osivelotor trials Research Report on Osivelotor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults Osivelotor, Famotidine - Healthy | Phase 1 | Recruiting | Pfizer | 52 | 2026-09-18 | 2026-10-21 |
| A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function Osivelotor - Liver Diseases | Phase 1 | Completed | Pfizer | 8 | 2024-04-30 | 2025-01-10 |
| GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD) Osivelotor - Sickle Cell Disease | Phase 2 / Phase 3 | Terminated | Pfizer | 47 | 2023-01-05 | 2026-03-19 |
| A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD Osivelotor - Sickle Cell Disease | Phase 2 / Phase 3 | Recruiting | Pfizer | 389 | 2022-09-22 | 2026-08-18 |
Anemia, Sickle Cell (2) · Liver Diseases (1)
Pfizer (4)
United States (3) · Nigeria (2) · Belgium (1) · Brazil (1) · India (1) · Kenya (1) · Saudi Arabia (1) · United Kingdom (1)
2023 (1)